Loading data for SCYX — first visit, this takes a few seconds.

알림

SCYNEXIS Inc. (SCYX)

NasdaqCM: SCYX · 실시간 가격 · USD

5.09

-0.09 (-1.74%)

종가 기준: Aug 18, 2026, 3:59 PM

-1.74% (1D)

매수호가	n/a
시가총액	50.64M
매출 (ttm)	19.22M
순이익 (ttm)	-10.23M
베타	1.10
EPS (ttm)	-0.89
P/E (ttm)	n/a
선행 P/E	-2.2
P/B (ttm)	0.96
P/S (ttm)	2.64
Earnings Date	Nov 4, 2026

매도호가	n/a
거래량	127,021
평균 거래량 (20일)	138,129
시가	5.20
전일 종가	5.18
일중 범위	4.90 - 5.50
52주 범위	3.53 - 10.48
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

SCYX 소개

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company w...

섹터 Healthcare

IPO 일자 May 2, 2014

직원 수 18

상장 거래소 NasdaqCM

티커 SCYX

웹사이트 https://www.scynexis.com

전체 기업 정보

재무 실적

2025년 SCYNEXIS의 매출은 20.6M로, 전년 3.75M 대비 449.95% 증가했습니다. 순이익은 -8.61M로, -59.56% 감소했습니다.

재무제표

어닝 서프라이즈

SCYNEXIS가 Aug 10, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 -100.00% 전년 대비 감소.

EPS 0.63 예상치 상회 1.14, 및 156.25% 전년 대비 성장.

다음 실적 발표

SCYNEXIS Inc.의 실적 발표 예정일은 Nov 4, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

2개월 전 · TipRanks

Upcoming Stock Splits This Week (June 1 to June 5) – Stay Invested

These are the upcoming stock splits for the week of June 1 to June 5, based on TipRanks’ Stock Splits Calendar. A stock split is a corporate move that increases the number of shares outstanding while ...

4개월 전 · MT Newswires

SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease

SCYNEXIS (SCYX) said Tuesday that it has entered into a securities purchase agreement with investors

5개월 전 · Insider Monkey

SCYNEXIS, Inc. (SCYX) Announces First Participants Dosed in Phase 1 Trial of SCY-247 Antifungal Therapy

SCYNEXIS, Inc. (NASDAQ:SCYX) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On February 26, 2026, SCYNEXIS, Inc. (NASDAQ:SCYX) announced that the first participants had been dosed in a...

5개월 전 · Associated Press Finance

Scynexis: Q4 Earnings Snapshot

The Jersey City, New Jersey-based company said it had profit of 25 cents per share. The pharmaceutical company posted revenue of $18.6 million in the period. For the year, the company reported a loss ...

9개월 전 · Simply Wall St.

Here's Why We're A Bit Worried About SCYNEXIS' (NASDAQ:SCYX) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

2 페이지 중 1

SCYNEXIS Inc. (SCYX)